Philhealth keeps unbeaten slate in Arena-7 hoopfest | Inquirer News

Philhealth keeps unbeaten slate in Arena-7 hoopfest

/ 07:14 AM December 04, 2011

PHILHEALTH kept its immaculate record in the 2011 Association of Regional Executives in National Agencies (ARENA)-7 basketball tournament after drubbing the Bureau of Internal Revenue (BIR)-Cebu, 62-48, last Friday.

The victory was Philhealth’s sixth straight to grab the solo lead in Group B.

Philhealth was ahead, 38-27 at the half with bull-strong center Albert Anadon and Nigel Catao leading the charge. But BIR retaliated in the 3rd period with a fierce, 11-7 run to trim its deficit to just seven points, 38-45, heading to the final quarter.

Article continues after this advertisement

However, Philhealth outscored BIR-Cebu in the fourth, 17-10 to post the 14-point demolition and hand the latter its first loss in the tournament.

FEATURED STORIES

Albert Anadon led Philhealth with a game-high 18 points while Carlo Yu added 10 markers. Cris Diamos and Allen Sorela paced BIR with 11 and 10 points, respectively.

BOX SCORES

Article continues after this advertisement

PHILHEALTH (62)- Anadon 18, Yu 10, Yap 9, Catao 7, Sasang 5, Magallanes 4, Derder 3, Palma 2, Ornopia 2, Quiñanola 2.

BIR (48)- Diamos 11, Sorela 10, Dizon 7, Galvez 6, Bonsucan 5, Del Rosario 4, Meso 2, California 2, Detorio 2, Alburo 1.  /Correspondent Dale Rosal

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Basketball, Philhealth

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.